We are live on ! Find out more
VXRT

Vaxart

Delisted

VXRT was delisted on the 7th of July, 2025.

100 hedge funds and large institutions have $31.9M invested in Vaxart in 2024 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 15 increasing their positions, 26 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more call options, than puts

Call options by funds: $301K | Put options by funds: $183K

18% more capital invested

Capital invested by funds: $27M → $31.9M (+$4.85M)

0% more funds holding

Funds holding: 100100 (0)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 17

1.3% less ownership

Funds ownership: 17.82%16.52% (-1.3%)

42% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 26

Holders
100
Holders Change
Holders Change %
0%
% of All Funds
1.44%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
17
Increased
15
Reduced
26
Closed
17
Calls
$301K
Puts
$183K
Net Calls
+$118K
Net Calls Change
+$153K

VXRT Hedge Fund Activity: Q3 2024 in Review

100 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q3 2024, worth a combined $31.9M — up 18% from $27M a quarter earlier.

Fund positioning in VXRT was balanced in Q3 2024: 17 funds opened new positions, 17 closed out, 15 added to existing stakes and 26 trimmed.

The largest buyer was Silverarc Capital Management, opening a new position worth an estimated $764K. The largest seller was Sio Capital Management, cutting an estimated $884K.

  • 100 institutional investors held Vaxart (VXRT) as of Q3 2024, unchanged from Q2 2024.
  • Funds reported $31.9M of Vaxart stock for Q3 2024, up 18% quarter-over-quarter.
  • 17 funds opened new Vaxart positions in Q3 2024 and 17 closed out, a net change of 0 holders.
  • The largest Vaxart buyer in Q3 2024 was Silverarc Capital Management, an estimated $764K added.
  • The largest Vaxart seller in Q3 2024 was Sio Capital Management, an estimated $884K sold.

Based on aggregated 13F filings for Q3 2024.